These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30289080)

  • 1. Should Cushing's Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines?
    Koracevic G; Stojkovic M; Lovic D; Pavlovic M; Kostic T; Kutlesic M; Micic S; Koracevic M; Djordjevic M
    Curr Vasc Pharmacol; 2020; 18(1):12-24. PubMed ID: 30289080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
    Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing's syndrome?
    Krarup T; Krarup T; Hagen C
    Diabetes Metab Res Rev; 2012 Mar; 28(3):219-27. PubMed ID: 22162117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome During Menopause.
    Mumusoglu S; Yildiz BO
    Curr Vasc Pharmacol; 2019; 17(6):595-603. PubMed ID: 30179134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.
    Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach.
    Varlamov EV; Langlois F; Vila G; Fleseriu M
    Eur J Endocrinol; 2021 Apr; 184(5):R207-R224. PubMed ID: 33539319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy.
    Terzolo M; Reimondo G; Chiodini I; Castello R; Giordano R; Ciccarelli E; Limone P; Crivellaro C; Martinelli I; Montini M; Disoteo O; Ambrosi B; Lanzi R; Arosio M; Senni S; Balestrieri A; Solaroli E; Madeo B; De Giovanni R; Strollo F; Battista R; Scorsone A; Giagulli VA; Collura D; Scillitani A; Cozzi R; Faustini-Fustini M; Pia A; Rinaldi R; Allasino B; Peraga G; Tassone F; Garofalo P; Papini E; Borretta G
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3467-75. PubMed ID: 22767639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokines and cardiovascular risk in Cushing's syndrome.
    Valassi E; Biller BM; Klibanski A; Misra M
    Neuroendocrinology; 2012; 95(3):187-206. PubMed ID: 22057123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic disorders during endogenous Cushing's syndrome: prevalence, associated factors, and outcome after remission.
    Chihaoui M; Oueslati I; Khessairi N; Chaker F; Cherni S; Hammami B; Feki M; Yazidi M
    Endocr Regul; 2023 Jan; 57(1):138-143. PubMed ID: 37561832
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic syndrome in Cushing's syndrome.
    Chanson P; Salenave S
    Neuroendocrinology; 2010; 92 Suppl 1():96-101. PubMed ID: 20829627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.
    Escoté X; Aranda GB; Mora M; Casals G; Enseñat J; Vidal O; Esteban Y; Halperin I; Hanzu FA
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):26-33. PubMed ID: 28440767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
    Tauchmanovà L; Rossi R; Biondi B; Pulcrano M; Nuzzo V; Palmieri EA; Fazio S; Lombardi G
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4872-8. PubMed ID: 12414841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
    Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
    Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women: Challenging the current definition.
    Dragsbæk K; Neergaard JS; Laursen JM; Hansen HB; Christiansen C; Beck-Nielsen H; Karsdal MA; Brix S; Henriksen K
    Medicine (Baltimore); 2016 Sep; 95(36):e4806. PubMed ID: 27603394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
    Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk in Cushing's syndrome.
    Arnaldi G; Mancini T; Polenta B; Boscaro M
    Pituitary; 2004; 7(4):253-6. PubMed ID: 16416038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac disease in Cushing's syndrome. Emphasis on the role of cardiovascular magnetic resonance imaging.
    Moustaki M; Markousis-Mavrogenis G; Vryonidou A; Paschou SA; Mavrogeni S
    Endocrine; 2024 Mar; 83(3):548-558. PubMed ID: 38129722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease in Cushing's syndrome: heart versus vasculature.
    De Leo M; Pivonello R; Auriemma RS; Cozzolino A; Vitale P; Simeoli C; De Martino MC; Lombardi G; Colao A
    Neuroendocrinology; 2010; 92 Suppl 1():50-4. PubMed ID: 20829618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of atherosclerosis in patients with Cushing's syndrome: a meta-analysis of literature studies.
    Lupoli R; Ambrosino P; Tortora A; Barba L; Lupoli GA; Di Minno MN
    Ann Med; 2017 May; 49(3):206-216. PubMed ID: 27763781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.